Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-04

Clinical Trial Update: A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effect of Vitamin D on progression-free survival in indolent non-Hodgkin lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Jonathan Friedberg | Conditions: Follicular Lymphoma, Small Lymphocytic Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2024-09-04